Pediatric and adolescent medicine· 2013· Book chapter
Hematological Problems in Pediatric Intensive Care
- 3,517citations
- 2013year
Short summary
Desmopressin (DDAVP) has been a safe and cost-effective treatment for children with von Willebrand disease and Hemophilia A for nearly 35 years, significantly reducing exposure to plasma-derived products.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Hematology
HematologyMedicine